COMPANY

GLAXOSMITHKLINE INC

GLAXOSMITHKLINE INC: marketing authorisation holder for Bacitracin, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

BacitracinCICATRIN POWDER (DIN 00666173), Cancelled Post Market Regulator Health Canada
BacitracinCORTISPORIN (DIN 00666246), Cancelled Post Market Regulator Health Canada
BacitracinCORTISPORIN (DIN 00701904), Cancelled Post Market Regulator Health Canada
BacitracinNEOSPORIN OINTMENT (DIN 00666122), Cancelled Post Market Regulator Health Canada
BacitracinNEOSPORIN OPHTHALMIC OINTMENT (DIN 00694398), Cancelled Post Market Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.